Summary
Twelve hour metabolic rhythms have been performed on six maturity-onset diabetic subjects during successive periods of therapy with phenformin, metformin, and glibenclamide. Moderate control of blood glucose concentration was achieved with phenformin and metformin, the lowest concentrations being found with glibenclamide. Mean blood lactate concentration was grossly elevated during phenformin therapy, moderately elevated with metformin and normal during glibenclamide treatment. Similar patterns were found for the lactate/pyruvate ratio, alanine, glycerol and ketone bodies. Serum triglyceride concentrations were significantly higher during phenformin treatment than with the other two regimes. Serum insulin concentration was higher on glibenclamide than with either biguanide. Most of these effects of the biguanides could be accounted for by an inhibitory effect on hepatic gluconeogenesis. It is concluded that the use of biguanides as hypoglycaemic agents in diabetes is associated with the production of multiple metabolic abnormalities.
Article PDF
Similar content being viewed by others
References
Caspary, W.F., Creutzfeldt, W.: Analysis of inhibitory effect of biguanides on glucose absorption: inhibition of active sugar transport. Diabetologia7, 379–385 (1971)
Czyzyk, A., Tawecki, J., Sadowski, J., Ponikowska, I., Szczepanik, Z.: Effect of biguanides on intestinal absorption of glucose. Diabetes17, 492–498 (1968)
Butterfield, W.J.H., Whichelow, M.J.: The hypoglycemic action of phenformin. Effect of phenformin on glucose metabolism in peripheral tissues. Diabetes11, 281–286 (1962)
Meyer, F., Ipaktchi, M., Clauser, H.: Specific inhibition of gluconeogenesis by biguanides. Nature213, 203–204 (1967)
Altschuld, R.A., Kruger, F.A.: Inhibition of hepatic gluconeogenesis in guinea pig by phenformin. Ann. N. Y. Acad. Sci.148, 612–622 (1968)
Cook, D.E., Blair, J.B., Lardy, H.A.: Mode of action of hypoglycaemic agents. V. Studies with phenethylbiguanide in isolated perfused rat liver. J. Biol. Chem.248, 5272–5277 (1973)
Medina, J.M., Sánchez-Medina, F., Mayor, F.: Effect of phenformin on gluconeogenesis in perfused rat liver. Rev. Esp. Fisiol.27, 253–256 (1971)
Varma, S.K., Heaney, S.J., Whyte, W.G., Walker, R.S.: Hyperlactataemia in phenformin-treated diabetics. Br. Med. J.1972 I, 205–206
Craig, J.W., Miller, M., Woodward, H., Merik, E.: Influence of phenethylbiguanide on lactic, pyruvic and citric acids in diabetic patients. Diabetes9, 186–193 (1960)
Debry, G., Anziani, C., Cherrier, P., Laurent, J.: Étude de la lactacidémie à jeun chez les diabétiques traités par le N-N-diméthylbiguanide. Le Diabete12, 239–245 (1964)
Assan, R., Heuclin, C., Girard, J.R., Lemaire, F., Attali, J.R.: Phenformin-induced lactic acidosis in diabetic patients. Diabetes24, 791–800 (1975)
Ball, S., Woods, H.F., Alberti, K.G.M.M.: Lacticacidosis, ketoacidosis, and hyperalaninaemia in a phenformin-treated diabetic patient. Br. Med. J.1974 IV, 699–700
Cohen, R.D., Woods, H.F.: Clinical and biochemical aspects of lactic acidosis. p. 166. Oxford: Blackwell Scientific Publications 1976
Cramp, D.G.: Automated fluorimetric techniques based on NAD- and NADP-linked enzyme systems in the study of intermediary carbohydrate metabolism. J. Med. Lab. Technol.27, 359–382 (1970)
Williamson, D.H., Mellanby, J., Krebs, H.A.: Enzymic determination of D(-)-β-hydroxybutyric acid and acetoacetic acid in blood. Biochem. J.82, 90–96 (1962)
Ho, R.J., Meng, H.C.: A simple and ultrasensitive method for determination of free fatty acid by radiochemical assay. Anal. Biochem.31, 426–436 (1969)
Holub, W.R.: Rapid, simplified continuous-flow colorimetry of serum triglycerides. Clin. Chem.19, 1391–1393 (1973)
Pearson, S., Stern, S., McGavack, T.H.: A rapid procedure for the determination of serum cholesterol. J. Clin. Endocrinol.12, 1245–1246 (1952)
Soeldner, J.S., Slone, D.: Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes14, 771–779 (1965)
Boden, G., Soeldner, J.S.: A sensitive double antibody radioimmunoassay for human growth hormone (HGH): levels of serum HGH following rapid tolbutamide infusion. Diabetologia3, 413–421 (1967)
Alberti, K.G.M.M., Domhorst, A., Rowe, A.S.: Metabolic rhythms in normal and diabetic man. Isr. J. Med. Sci.2, 571–580 (1975)
Caspary, W.F., Creutzfeldt, W.: Inhibition of intestinal amino acid transport by blood sugar lowering biguanides. Diabetologia9, 6–12 (1973)
Tomkin, G.H.: Malabsorption of vitamin B12 in diabetic patients treated with phenformin: a comparison with metformin. Br. Med. J.1973 III, 673–675
Creutzfeldt, W., Willms, B., Caspary, W.: The mechanism of action of the blood glucose lowering biguanides. In: Diabetes. Proceedings of the VIIth Congress of the International Diabetes Federation. Buenos Aires, 1970 (eds. R.R. Rodriguez, J. Vallance-Owen), pp. 708–719. Amsterdam: Excerpta Medica 1971
Searle, G.L., Schilling, S., Porte, D., Barbaccia, J., De Grazia, J., Cavalieri, R.R.: Body glucose kinetics in non-diabetic human subjects after phenethylbiguanide. Diabetes15, 173–178 (1966)
Fajans, S.S., Moorhouse, J.A., Doorenbos, H., Louis, L.H., Conn, J.W.: Metabolic effects of phenethylbiguanide in normal subjects and in diabetic patients. Diabetes9, 194–201 (1960)
Lyngsoe, J., Bitsch, V., Trap-Jensen, J.: Influence of phenformin on fat and lactate metabolism and insulin production in starved normal subjects. Metabolism21, 179–186 (1972)
Nattrass, M., Lloyd, B., Todd, P.G.: Metabolic effects of combined sulphonylurea and biguanide therapy. Diabetologia12, (Abstr.) 411 (1976)
Ogata, K., Jomain-Baum, M., Hanson, R.W.: Phenethylbiguanide and the inhibition of hepatic gluconeogenesis in the guinea pig. Biochem. J.144, 49–57 (1974)
Toews, C.J.: USV Workshop Discussion: metabolic effects of biguanides, p. 29. Paris, 1975
Schäfer, G.: Some new aspects on the interaction of hypoglycemia-producing biguanides with biological membranes. Biochem. Pharmacol.25, 2015–2024 (1976)
Walker, R.S., Linton, A.L.: Phenethylbiguanide: a dangerous side effect. Br. Med. J.1959 II, 1005–1006
Wildenhoff, K.E.: The influence of diabetic regulation on the diurnal variation in blood and the urinary excretion of ketone bodies. Acta. Med. Scand.198, 127–133 (1975)
Kattermann, R., Appels, A., Hubrich, K., Proschek, H., Söling, H.D., Creutzfeldt, W.: Untersuchungen über die Wirkung von Diät, Tolbutamid und Buformin sowie deren Kombination auf Körpergewicht und verschiedene Stoffwechselgröβen bei Diabetikern. II. Freie Fettsäuren, Ketonkörper, Triglyceride und Cholesterin im Blut. Diabetologia4, 221–228 (1968)
Alberti, K.G.M.M., Holloway, P.A.H., Johnson, G., Man, K.C., Nattrass, M.: Biguanides and ketone body metabolism in animals and man. In: Biochemical and clinical aspects of ketone body metabolism (ed. H.D. Soling), Stuttgart: Georg Thieme Verlag 1977
Alterman, S.L., Lopez-Gomez, A.A.: Phenformin effect on body weight lipids, and glucose regulation. Ann. N. Y. Acad. Sci.148, 884–891 (1968)
Mirsky, S.: Influence of hypoglycemic therapy on blood lipids and body weight in diabetes mellitus. Ann. N. Y. Acad. Sci.148, 937–944 (1968)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nattrass, M., Todd, P.G., Hinks, L. et al. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics. Diabetologia 13, 145–152 (1977). https://doi.org/10.1007/BF00745143
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00745143